Lab Lafage
FDA import alert and refusal historyBofasa, GuatemalaFEI 3043016810
Recorded by FDA as LAB LAFAGE
As of October 26, 2026, Lab Lafage is not on any FDA import alert in SupplierRadar's records; FDA refused 1 of its shipment line on September 25, 2026, most often for unapproved new drug (UNAPPROVED).
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- Not listed
- Last import refusal
- Vitamin e (tocopherol) · UNAPPROVED
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Lab Lafage
1 record, newest first. Each line links to the FDA page it came from.
2026
- Import refusalRefused, Vitamin e (tocopherol)UNAPPROVEDEntry 1FX-4166735-4Source
Refusal charges, in plain English
- UNAPPROVED1 refused line
Unapproved new drug
The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.
Questions about Lab Lafage
- Is Lab Lafage on an FDA import alert?
- No listing for Lab Lafage appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Guatemala page.
- Has FDA refused shipments from Lab Lafage?
- Yes. FDA refused 1 shipment line from Lab Lafage on September 25, 2026. The most recent, on September 25, 2026, was vitamin e (tocopherol), charged as UNAPPROVED (unapproved new drug).
- Why did FDA refuse Lab Lafage's shipments?
- The most frequent charge is UNAPPROVED (unapproved new drug, 1 line).
- What is Lab Lafage's FEI number?
- Lab Lafage's FDA Establishment Identifier (FEI) is 3043016810.
Buying from Lab Lafage?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.